The 81st Annual Meeting of the Japanese Society of Hematology

Presentation information

Print

Luncheon Seminar

LS2-12 Thinking about haemophilia treatment from the factor IX modification technology and their mode of action.

Sat. Oct 12, 2019 12:15 PM - 1:00 PM No.12 (Tokyo International Forum, 5F G510)

Chair: Midori Shima（Department of Pediatrics Nara Medical University）

Sponsor: Novo Nordisk Pharma Ltd.

[LS2-12] Thinking about haemophilia treatment from the factor IX modification technology and their mode of action.

Keiji Nogami (Department of Pediatrics Nara Medical University)

Abstract password authentication.
Password is required to view the abstract. Please enter a password to authenticate.Password is written on a program book.

Password